Skip to content

Wave Life Sciences

US · WVE #3515 by market cap Listed 2015
3.54 +0.02 +0.57%
Live - 5344 symbols - heartbeat 300s ago · 2026-10-08 09:02
Pre-market 3.54 0.00%
After-hours 3.54 -0.06%
Market cap
697.55M
P/B
1.54
EPS
-1.21
Reader sentiment Are you bullish or bearish on WVE?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $12 to $26
    Market Newswire · 2026/7/31
  • Rating change
    A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $13 to $15
    Market Newswire · 2026/5/19
  • Rating change
    Mizuho Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $27
    Market Newswire · 2026/6/13
  • Rating change
    Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14
    Market Newswire · 2026/9/10
  • Rating change
    B. Riley Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $22
    Market Newswire · 2026/7/31
  • Rating change
    Wedbush Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15
    Market Newswire · 2026/5/28
  • Rating change
    Clear Street Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $26
    Market Newswire · 2026/8/3
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), BrightSpring Health Services, Inc. (BTSG) and AgomAb Therapeutics NV ADR (AGMB)
    TipRanks · 2026/8/3
  • Rating change
    RBC Capital Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15
    Market Newswire · 2026/7/31
  • Rating change
    B. Riley Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $31
    Market Newswire · 2026/4/30
  • Rating change
    CCORF Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $43
    Market Newswire · 2026/5/20
  • Rating change
    Mizuho Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $23
    Market Newswire · 2026/8/3
  • Rating change
    B. Riley Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
    TipRanks · 2026/7/31
  • Rating change
    Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $14
    Market Newswire · 2026/5/20
  • Rating change
    J.P. Morgan Initiates Wave Life Sciences(WVE.US) With Hold Rating
    Market Newswire · 2026/9/23
  • Wedbush Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $12
    Market Newswire · 2026/10/1
  • H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $13
    Market Newswire · 2026/10/2
  • Ladenburg Thalmann Initiates Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $10
    Market Newswire · 2026/10/1
  • BofA Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/10/2
  • Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating
    Market Newswire · 2026/10/2

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 09:02:42 · For reference only, not investment advice and not tailored to your situation.